Is Canada patent deal obstructing Ebola vaccine development?

被引：6

作者：

Attaran, Amir ^{[1
]}

Nickerson, Jason W. ^{[2
]}

机构：

[1] Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada

[2] Bruyere Res Inst, Ottawa, ON, Canada

来源：

关键词：

D O I：

10.1016/S0140-6736(14)62044-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E61 / E61

页数：1

共 6 条

[1]

[Anonymous], 2004, Sole license agreement for recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers, Patent No. 2004011488

[2]

[Anonymous], 2014, The Economist

[3]

[Anonymous], 2014, POLITICS

[4]

Falzarano D, 2011, EXPERT REV VACCINES, V10, P63, DOI [10.1586/erv.10.152, 10.1586/ERV.10.152]

Jones, SM ;

Feldmann, H ;

Ströher, U ;

Geisbert, JB ;

Fernando, L ;

Grolla, A ;

Klenk, HD ;

Sullivan, NJ ;

Volchkov, VE ;

Fritz, EA ;

Daddario, KM ;

Hensley, LE ;

Jahrling, PB ;

Geisbert, TW .

[6]

Kupferschmidt K, EBOLA VACCINE TESTS